The modified sequential treatment regimen containing levofloxacin for helicobacter pylori eradication in Turkey

Helicobacter

Volumn 14, Issue 6, 2009, Pages 520-524

  Aydin, Ahmet ^a   Oruc, Nevin ^a   Turan, Ilker ^a   Ozutemiz, Omer ^a   Tuncyurek, Muge ^a   Musoglu, Ahmet ^a  

^a EGE UNIVERSITY   (Turkey)

Author keywords

Eradication; Helicobacter pylori; Levofloxacin; Sequential

Indexed keywords

AMOXICILLIN; LEVOFLOXACIN; METRONIDAZOLE; RABEPRAZOLE;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGED; APPETITE; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; FEMALE; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; TASTE; THERAPY EFFECT; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME; TURKEY (REPUBLIC);

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AGED; AGED, 80 AND OVER; AMOXICILLIN; ANTI-BACTERIAL AGENTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; OFLOXACIN; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

HELICOBACTER PYLORI;

EID: 70449399157     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2009.00720.x     Document Type: Article

References (34)

1. Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002 347 : 1175 1186.
2. Seyda T, Derya C, Fusun A, et al. The relationship of Helicobacter pylori positivity with age, sex, and ABO/Rhesus blood groups in patients with gastrointestinal complaints in Turkey. Helicobacter 2007 12 : 244 250.
3. Malfertheiner P, Mégraud F, Morain CO, et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther 2002 16 : 167 180.
4. Vakil N, Lanza F, Schwartz H, et al. Seven-day therapy for Helicobacter pylori in the United States. Aliment Pharmacol Ther 2004 20 : 99 107.
5. Kadayifci A, Buyukhatipoglu H, Savas CM, et al. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years. Clin Ther 2006 2811 : 1960 1966.
6. Onder G, Aydin A, Akarca U, et al. High Helicobacter pylori resistance rate to clarithromycin in Turkey. J Clin Gastroenterol 2007 418 : 747 750.
7. Al-Eidan FA, McElnay JC, Scott MG, et al. Management of Helicobacter pylori eradication - the influence of structured counselling and follow-up. Br J Clin Pharmacol 2002 53 : 163 171.
8. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of H. pylori with triple therapy. Gastroenterology 1992 102 : 493 496.
9. Cirak MY, Engin D, Unal S, et al. Monitoring of Helicobacter pylori resistance to clarithromycin by real-time PCR assay in gastric biopsy specimens over a 4-year period in turkey. Helicobacter 2007 12 : 449.
10. Zullo A, Rinaldi V, Winn S, et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Aliment Pharmacol Ther 2000 146 : 715 718.
11. Graham DY, Abudayyeh S, El-Zimaity HM, et al. Sequential therapy using high-dose esomeprazole-amoxicillin followed by gatifloxacin for Helicobacter pylori infection. Aliment Pharmacol Ther 2006 245 : 845 850.
12. Shehada S, Srugo I, Shaoul R. Failure of sequential therapy to eradicate Helicobacter pylori in previously treated subjects. Helicobacter 2007 126 : 645 647.
13. Uygun A, Kadayifci A, Ercin CN, et al. Birinci basamak helikobakter pilori eradikasyonunda iki farkli ardisik protokolun klasik uclu tedavi ile karsilastirilmasi (Abstract). Turk J Gastroenterol 2008 19 (Supp. 1 21.
14. Di Caro S, Franceschi F, Mariani A, et al. Second-line levofloxacin-based triple schemes for Helicobacter pylori eradication. Dig Liver Dis 2009 41 : 480 485.
15. European Agency for the Evaluation of Medicinal Products, International Conference on Harmonisation- World Health Organization. Guideline for Good Clinical Practice [EMEA Web site]. ICH Topic E6. Canary Wharf, UK : EMEA 2002.
16. Salako SE. The Declaration of Helsinki 2000: ethical principles and the dignity of difference. Med Law 2006 25 : 341 354.
17. Cutler AF, Schubert TT. Patient factors affecting H. pylori eradication with triple therapy. Am J Gastroenterol 1993 88 : 505 509.
18. De Francesco V, Margiotta M, Zullo A, et al. Clarithromycin-resistant genotypes and eradication of Helicobacter pylori. Ann Intern Med 2006 144 : 94 100. (Pubitemid 46768227)
19. De Francesco V, Margiotta M, Zullo A, et al. Primary clarithromycin resistance in Italy assessed on Helicobacter pylori DNA sequences by TaqMan real-time polymerase chain reaction. Aliment Pharmacol Ther 2006 233 : 429 435.
20. Zullo A, Perna F, Hassan C, et al. Primary antibiotic resistance in Helicobacter pylori strains isolated in northern and central Italy. Aliment Pharmacol Ther 2007 25 : 1429 1434. (Pubitemid 46848887)
21. Uygun A, Kadayifci A, Yesilova Z, et al. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clin Ther 2008 303 : 528 534.
22. Sezgin O, Altintaş E, Nayir E, et al. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. Helicobacter 2007 126 : 629 632.
23. Saad RJ, Schoenfeld P, Kim HM, et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy for persistent Helicobacter pylori infection: a meta-analysis. Am J Gastroenterol 2006 101 : 488 496.
24. Nista EC, Candelli M, Zocco MA, et al. Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication. Am J Gastroenterol 2006 101 : 1985 1990.
25. Gisbert JP, Bermejo F, Castro-Fernández M, et al. Second-line rescue therapy with levofloxacin after H. pylori treatment failure: a Spanish multicenter study of 300 patients. Am J Gastroenterol 2008 10 : 71 6.
26. Ermis F, Akyuz F, Pinarbasi B, et al. Effectiveness of seven days levofloxacin triple therapy in H Pylori eradication (Abstract). Turk J Gastroenterol 2007 18 (Suppl. 1 60.
27. Graham DY, Lu H, Yamaoka Y. A report card to grade Helicobacter pylori therapy. Helicobacter 2007 12 : 275 278.
28. Chang WL, Sheu BS, Cheng HC, et al. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan. J Gastroenterol Hepatol 2009 24 : 1230 1235.
29. Romano M, Iovene MR, Russo MI, et al. Failure of first-line eradication treatment significantly increases prevalence of antimicrobial-resistant Helicobacter pylori clinical isolates. J Clin Pathol 2008 61 : 1112 1115.
30. De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure. Aliment Pharmacol Ther 2004 19 : 407 414.
31. Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Ann Intern Med 2008 148 : 923 931.
32. De Francesco V, Faleo D, Panella C, et al. Sequential eradicating therapy: a treatment that does not discriminate Helicobacter pylori strains in patients with nonulcer dyspepsia? Am J Gastroenterol 2002 97 : 2686 2687.
33. Williams MP, Pounder RE. Review article: the pharmacology of rabeprazole. Aliment Pharmacol Ther 1999 13 (Suppl. 3 3 10.
34. Stedman CA, Barclay ML. Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Aliment Pharmacol Ther 2000 14 : 963 978.